// App-Quantinova.ai

PB1329 : The predictive value of pulmonary infarction in patients with acute pulmonary embolism on persistent symptoms and adverse events

Researchers

Presenter

  • F. Kaptein

Principal Investigators

  • L. Kroft

  • L. van Dam

  • M. Ninaber

  • M. Huisman

  • F. Klok

Medical Centers

  • Leiden University Medical Centre, Leiden, Netherlands

  • Department of Urology, Leiden Unviersity Medical Center, Leiden, Netherlands

  • Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands

  • Department of Medicine – Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands

  • ,Leiden University Medical Center, Leiden, The Netherlands, Leiden, Zuid-Holland, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Genetic Disorder

  • Pulmonary/Respiratory Diseases

  • Ophthalmology (OP)

  • Blood/haematological Diseases

Disease

  • Pulmonary embolism

  • Venous thrombosis

  • Dyspnea

  • Cataract 6, multiple types

Biomarkers

  • EPH Receptor A2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Double Blind/Blinded

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved